The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising committee - Scorecard - MDSpire

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising committee

  • November 9, 2023

  • 0 min

Share

Clinical Scorecard: 49th Annual Conference of the European Society for Blood and Marrow Transplantation: Organizing Committee Overview

At a Glance

CategoryDetail
ConditionBlood and marrow transplantation and related hematologic conditions
Key MechanismsMultidisciplinary collaboration and scientific exchange in hematopoietic stem cell transplantation
Target PopulationPatients requiring blood and marrow transplantation, including those with acute leukemia, aplastic anemia, autoimmune diseases, chronic malignancies, inborn errors, infectious diseases, lymphoma, and pediatric diseases
Care SettingSpecialized transplant centers and hematology departments across Europe and internationally

Key Highlights

  • The conference is a hybrid meeting held from 23–26 April 2023, sponsored by the European Society for Blood and Marrow Transplantation (EBMT).
  • The Scientific Organising Committee comprises international experts from multiple countries, reflecting a broad multidisciplinary approach.
  • The EBMT includes multiple working parties focusing on specific disease areas and transplant complications, promoting specialized research and clinical practice.

Guideline-Based Recommendations

Diagnosis

  • Utilize multidisciplinary expertise from various working parties to guide diagnosis in hematologic and transplant-related conditions.

Management

  • Implement evidence-based transplantation protocols developed and reviewed by EBMT working parties and committees.
  • Engage in continuous education and research as facilitated by the EBMT Education portfolio.

Monitoring & Follow-up

  • Monitor transplant outcomes and complications through EBMT Registry and Quality Management Group initiatives.

Risks

  • Address transplant complications with guidance from the Transplant Complications Working Party.
  • Consider infectious disease risks managed by the Infectious Diseases Working Party.

Patient & Prescribing Data

Patients undergoing hematopoietic stem cell transplantation for various hematologic diseases.

Treatment approaches are informed by specialized working parties and committees focusing on disease-specific and transplant-related issues.

Clinical Best Practices

  • Foster collaboration among international experts to optimize transplantation outcomes.
  • Engage multidisciplinary teams including nurses, pharmacists, and data management specialists for comprehensive care.
  • Utilize registry data and quality management to continuously improve clinical protocols.

References

Original Source(s)

Related Content